T1	intervention 0 19	Omega-3 fatty acids
T2	condition 43 83	paclitaxel-induced peripheral neuropathy
T3	eligibility 643 670	patients with breast cancer
T4	control 821 828	placebo
T5	intervention-value 1021 1031	Twenty one
T6	intervention-value 1042 1045	70%
T7	intervention-participants 1102 1104	30
T8	outcome 1122 1124	PN
T9	control-value 1138 1143	40.7%
T10	control-value 1145 1147	11
T11	control-participants 1183 1185	27
T12	outcome 1225 1237	PN incidence
T13	outcome 1388 1405	frequencies of PN
